The February Newsletter is now available. You can see this and past newsletters in the DIDB Resource Center. Please note that you must be signed in to access.
Do not hesitate to contact us with comments or suggestions.
News
Finalized FDA DDI guidances now available in the DIDB Resource Center
New finalized In Vitro & Clinical Drug Interaction Studies FDA guidances (January 2020) are now available in the DIDB Resource Center. Please note that you must be signed in to access.
Lists of Sensitive Substrates, Inhibitors and Inducers updated + New Combined List
The lists of sensitive substrates, inhibitors, and inducers have been updated and are available in the Resource Center.
Note that we are working on improving the consistency of the presentation so you may notice small changes in some of the drug names or therapeutic classes. Also, for the same reason, we are now presenting all changes in exposure as AUC ratios.
Finally, you will find a new Excel file, combining all the information, so that you can search easily using any of the headings (drug name, therapeutic class, CYP…). Any feedback on this new combined file is welcome!
As always, feel free to contact us if you have any questions or comments.
January Newsletter
The January Newsletter is now available. You can see this and past newsletters in the DIDB Resource Center. Please note that you must be signed in to access.
Do not hesitate to contact us with comments or suggestions.
December Newsletter
The December Newsletter is now available. You can see this and past newsletters in the DIDB Resource Center. Please note that you must be signed in to access.
Do not hesitate to contact us with comments or suggestions.
November Newsletter
The November Newsletter is now available. You can see this and past newsletters in the DIDB Resource Center. Please note that you must be signed in to access.
Do not hesitate to contact us with comments or suggestions.
Lists of Sensitive Substrates, Inhibitors and Inducers updated
The lists of sensitive substrates, inhibitors, and inducers have been updated and are available in the Resource Center.
As always, feel free to contact us if you have any questions or comments.
October Newsletter available
The October Newsletter is now available. You can see this and past newsletters in the DIDB Resource Center. Please note that you must be signed in to access.
Do not hesitate to contact us with comments or suggestions.
We are now druginteractionsolutions.org
We have changed our domain to match our new name of UW Drug Interaction Solutions. We feel this name change better reflects our expanding activities and offerings.
All old bookmarks and links will still work, they will be redirected to the same page on our new domain.
If you have any questions or issues please contact us.
As always, don’t forget to check us out and follow us on Linked.
New queries available for beta testing
New queries are now available for beta testing under “FDA Marker Queries”. They allow you to search for in vitro and clinical data for inhibitors of CYP markers, and, in a second step from the query results page, view clinical concentrations of each inhibitor.
We are looking forward to your feedback!